1 active not recruiting, 1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow OPSCC: new trials by email Literature Review of OPSCC trials Research Report on OPSCC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma Ivonescimab（AK112，a PD-1/VEGF bispecific antibody） - HNSCC, OSCC | Active not recruiting | Zhujiang Hospital | 20 | 2026-01-26 | 2026-10-27 | |
| Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma de-intensified radiation - OPSCC, Oropharyngeal Squamous Cell Carcinoma (SCC) | Phase 2 | Not yet recruiting | University of Vermont Medical Center | 20 | 2025-01-01 | 2025-01-06 |
Squamous Cell Carcinoma of Head and Neck (2)
Carcinoma (2) · Carcinoma, Squamous Cell (2) · Head and Neck Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2)
University of Vermont Medical Center (1) · Zhujiang Hospital (1)
China (1)